These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4404209)

  • 1. Preliminary report of a new -adrenergic blocking agent in Thai patients with cardiac hyperactivity.
    Sathienchoke P; Sumruatruamphul N
    J Med Assoc Thai; 1972 Aug; 55(8):464-9. PubMed ID: 4404209
    [No Abstract]   [Full Text] [Related]  

  • 2. The treatment of functional heart disorders with beta-adrenergic blocking agents.
    Imhof P; Brunner H
    Postgrad Med J; 1970 Nov; ():Suppl:96-9. PubMed ID: 4395467
    [No Abstract]   [Full Text] [Related]  

  • 3. Beta adrenergic blocking drugs. Present position and future development.
    Fitzgerald JD
    Acta Cardiol; 1972; ():Suppl 15:199-2. PubMed ID: 4147608
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of adrenergic beta receptor blockaders on centrally caused sympathetic hyperactivity in children].
    Diekmann L; Höhfeld J
    Arztl Forsch; 1971 Oct; 25(10):335-40. PubMed ID: 4398952
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta-adrenergic blocking agents: review and update.
    Squire A; Kupersmith J
    Mt Sinai J Med; 1985 Sep; 52(7):553-8. PubMed ID: 2866443
    [No Abstract]   [Full Text] [Related]  

  • 6. Extract of Lycopus europaeus L. reduces cardiac signs of hyperthyroidism in rats.
    Vonhoff C; Baumgartner A; Hegger M; Korte B; Biller A; Winterhoff H
    Life Sci; 2006 Feb; 78(10):1063-70. PubMed ID: 16150466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiospecific beta-adrenergic blockade in the treatment of nervous heart symptoms.
    Thulesius O; Hansson R; List E
    Curr Ther Res Clin Exp; 1973 Nov; 15(11):805-14. PubMed ID: 4148032
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances.
    Kirch W; von Gizycki C
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):233-5. PubMed ID: 6104636
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical pharmacology of a new beta-adrenergic blocking agent--Trasicor].
    Votchal BE; Zamotaev IP; Lozinskiĭ LG; Sandomirskiĭ BL; Vorob'eva ZV
    Ter Arkh; 1973 Aug; 45(8):10-4. PubMed ID: 4149629
    [No Abstract]   [Full Text] [Related]  

  • 10. Is the relationship between beta-blocker-induced heart rate lowering and cardiovascular outcomes the result of confounding by indication?
    Phillips RA
    J Am Coll Cardiol; 2009 Jun; 53(22):2101; author reply 2106-7. PubMed ID: 19477364
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta-adrenergic blocking agents in cardiology.
    Padmavati S; Arora R
    J Assoc Physicians India; 1976 Nov; 24(11):725-8. PubMed ID: 15963
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adrenergic receptors and beta-blocking agents in coronary pathology].
    Chemin P; Rossi A
    Ann Cardiol Angeiol (Paris); 1974 Oct; 23(5):427-40. PubMed ID: 4155261
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiarrhythmic activity of esmolol (ASL-8052)--a novel ultra-short acting beta-adrenoreceptor blocking agent.
    Klein G; Wirtzfeld A; Alt E; Steck J; Saunders R; Hulse J; Kartzinel R; Lee R; Laddu AR
    Int J Clin Pharmacol Ther Toxicol; 1984 Feb; 22(2):112-7. PubMed ID: 6142005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uses and abuses of beta adrenergic blocking agents.
    Bhatia ML; Dalal S
    J Assoc Physicians India; 1976 Nov; 24(11):785-94. PubMed ID: 15972
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical-pharmacological evaluation of a new beta blocker, GYKI-41099 (tobanum).
    Török E; Istvánffy M; Halmágyi M; Wagner M; Csukás M
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):200-7. PubMed ID: 6104634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action and pharmacological classification of beta-adrenergic receptor blocking drugs.
    Singh BN
    Singapore Med J; 1973 Sep; 14(3):400-2. PubMed ID: 4149718
    [No Abstract]   [Full Text] [Related]  

  • 17. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adrenergic beta blocking agents in clinical medicine: hopes and disappointments].
    Cosma M
    Rev Med Chir Soc Med Nat Iasi; 1974; 78(4):992-4. PubMed ID: 4156087
    [No Abstract]   [Full Text] [Related]  

  • 19. [Nurses' drug information. Therapeutic main group: beta receptor blocking drugs. Use in cardiology. 1].
    Lumholtz IB
    Sygeplejersken; 1975 Apr; 75(16):17. PubMed ID: 235799
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of preliminary blockade of alpha- and beta-adrenoreceptors on stress-induced disorders of myocardial relaxation and contractile functions].
    Pshennikova MG; Vorontsova EIa
    Biull Eksp Biol Med; 1983 Dec; 96(12):55-7. PubMed ID: 6140967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.